The restructuring events database contains factsheets with data on large-scale restructuring events reported in the principal national media and company websites in each EU Member State. This database was created in 2002.
Manufacturing Manufacture Of Chemicals And Pharamceuticals Manufacture Of Basic Pharmaceutical Products And Pharmaceutical Preparations 21.2 - Manufacture of pharmaceutical preparations
150 jobs Number of planned job creations
Announcement Date
15 April 2021
Employment effect (start)
15 April 2021
Foreseen end date
Description
American vaccine manufacturer Moderna has announced that it will create at least 150 jobs at its new global shared services centre in Warsaw. The recruitment process has been initiated; currently, the company is looking for HR department employees as well as the unit’s director. The centre will provide services in finance, pharmacovigilance, HR, digitization and compliance.
Moderna is a Massachusetts-based biotechnology company established in 2010; the company is focused on the development of mRNA technology, instrumental in the COVID-19 vaccination campaign. Currently, the company employs 1,300 people worldwide.
Eurofound (2021), Moderna, Business expansion in Poland, factsheet number 104611, European Restructuring Monitor. Dublin, https://restructuringeventsprod.azurewebsites.net/restructuring-events/detail/104611.
Digitisation and automation technologies, including artificial intelligence (AI), can affect working conditions in a variety of ways and their use in the workplace raises a host of new ethical concerns.
The retail banking sector is fertile ground for studying the impacts of digitalisation on work and employment. Financial services are increasingly provided online, without the intermediary of customer-facing institutions.
European labour markets have recovered strongly from COVID-19. By the end of 2021, little more than 18 months after the start of the pandemic, employment rates in the EU were almost at pre-crisis levels.
